This refutes their statement about the halt of the Nanotainer having been a voluntary decision, as it was clearly mandated by the FDA.
"Theranos founder and Chief Executive Elizabeth Holmes confirmed the company had sharply curtailed its use of the vials, which it calls nanotainers, but presented it as a voluntary move."